In-Use Microbial Stability


The purpose of the working group is to share industry experience, to define and implement strategies to clarify FDA expectations, and to collectively collaborate with FDA on this topic. This will allow sponsors to apply risk-based approach to appropriately justify the in-use hold times and provide more flexibility to the hospitals. This can be achieved through the following objectives.